Being diagnosed with a malignant brain tumor is devastating news for patients and their loved ones. Whereas some types of tumor respond well to treatment, others such as glioblastomas – the most common and aggressive brain tumors – are known to recur and progress within short times from the diagnosis. Patients diagnosed with this type of cancer, and who undergo current standard treatment, have a median survival of 16 months.
Migraine Québec would like to invite you to attend a conference given by Dr. Guy Boudreau about scientific research and migraines.
The Data Warehouse will be unavailable due to an upgrade on Sunday, April 2, 2017 from 9:00 am to approximately 12:00 pm (noon).
Research Seminar - Service Receipt for Individuals with Autism across Canada: Findings from a Canadian National Survey by Jonathan Lai
Caregivers face various challenges navigating the service sectors for their children with autism across the lifespan, leading to a high level of burden and distress in families.
PhD defence of Mr. Ming Ma – Multi-Channel Simultaneous Optical and Microwave Signal Processing in Integrated Mode-Selective Silicon Devices
Departmental Seminar: Representation of land Heterogeneity and land-atmosphere interactions in CRCM5 and their role in modulating the regional climate and hydrology over North America by Laxmi Sushama